BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11726916)

  • 1. Lost in translation.
    Julier C
    Nat Genet; 2001 Dec; 29(4):358-9. PubMed ID: 11726916
    [No Abstract]   [Full Text] [Related]  

  • 2. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
    Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
    Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular medicine: lost in translation.
    Ainsworth C
    Nature; 2005 Jun; 435(7042):556-8. PubMed ID: 15931189
    [No Abstract]   [Full Text] [Related]  

  • 4. Defective translation initiation causes vanishing of cerebral white matter.
    Scheper GC; Proud CG; van der Knaap MS
    Trends Mol Med; 2006 Apr; 12(4):159-66. PubMed ID: 16545608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy.
    Mascalchi M; De Grandis D; Ginestroni A; Pratesi A; Della Nave R; Scheper GC; van der Knaap MS
    Neurology; 2006 Aug; 67(3):537-8. PubMed ID: 16894129
    [No Abstract]   [Full Text] [Related]  

  • 6. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ten novel mutations in patients with eIF2B-related disorders.
    Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
    Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
    Pronk JC; Leegwater PA; van der Knaap MS
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of ovarioleukodystrophy without eIF2B mutations.
    Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
    J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in functional study of EIF2B mutations in leukoencephalopathy with vanishing white matter].
    Leng XR; Wu Y; Jiang YW
    Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):125-8. PubMed ID: 21416999
    [No Abstract]   [Full Text] [Related]  

  • 11. The ovarioleukodystrophy.
    Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic initiation factor 2B and its role in alterations in mRNA translation that occur under a number of pathophysiological and physiological conditions.
    Kubica N; Jefferson LS; Kimball SR
    Prog Nucleic Acid Res Mol Biol; 2006; 81():271-96. PubMed ID: 16891174
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
    Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [eIF2B and Cree Indian leukodystrophies].
    Fogli A; Rodriguez D; Eymard-Pierre E; Boespflug-Tanguy O
    Med Sci (Paris); 2003 Mar; 19(3):283-4. PubMed ID: 12836410
    [No Abstract]   [Full Text] [Related]  

  • 15. Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F.
    Sans MD; DiMagno MJ; D'Alecy LG; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G517-28. PubMed ID: 12773302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of translational control of eukaryotic gene expression using yeast.
    Hinnebusch AG; Asano K; Olsen DS; Phan L; Nielsen KH; Valásek L
    Ann N Y Acad Sci; 2004 Dec; 1038():60-74. PubMed ID: 15838098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
    Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
    Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-eIF2B-related cystic leukoencephalopathy of unknown origin.
    van der Knaap MS; Scheper GC
    Ann Neurol; 2006 Apr; 59(4):724. PubMed ID: 16566013
    [No Abstract]   [Full Text] [Related]  

  • 19. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy.
    Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F
    Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
    Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.